Intervention

busulfan

ClinicalTrials.gov intervention label

Clinical trials6
Recruiting0
Common conditions22
Lead sponsors shown5

Clinical trials

6 shown
Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaNCT01961063 · 2015-12-31
ACTIVE_NOT_RECRUITING
Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related LymphomaNCT00005824 · 2000-11-01
COMPLETED
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryNCT00006126 · 1999-09-01
WITHDRAWN
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast CancerNCT00003972 · 1998-07-01
COMPLETED
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerNCT00003199 · 1997-11-01
COMPLETED
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsNCT00060255 · 1991-12-01
COMPLETED

Common conditions

Breast Cancer3Lymphoma2Testicular Germ Cell Tumor2AIDS-related Non-Hodgkin Lymphoma1AIDS-related Plasmablastic Lymphoma1AIDS-related Primary Effusion Lymphoma1Estrogen Receptor-negative Breast Cancer1Estrogen Receptor-positive Breast Cancer1HIV Infection1Inflammatory Breast Cancer1Kidney Cancer1Leukemia1Lung Cancer1Male Breast Cancer1Melanoma (Skin)1Multiple Myeloma and Plasma Cell Neoplasm1Progesterone Receptor-negative Breast Cancer1Progesterone Receptor-positive Breast Cancer1Stage IIIB Breast Cancer1Stage IV Breast Cancer1Unspecified Adult Solid Tumor, Protocol Specific1Unspecified Childhood Solid Tumor, Protocol Specific1

Trial status mix

COMPLETED4
ACTIVE_NOT_RECRUITING1
WITHDRAWN1

Phase mix

PHASE23
PHASE12
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.